COMMUNIQUÉS West-GlobeNewswire

BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
15/03/2024
Newly granted patent aligns with Company’s focus on expanding geographic coverage and strengthening intellectual property protection for BXCL501 NEW HAVEN, Conn., March 15, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics [...]
Mesa Labs Releases Second Annual Responsible Business Program Brochure
15/03/2024
LAKEWOOD, Colo, March 15, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB, “Mesa” “we” “our” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality [...]
Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
15/03/2024
RESEARCH TRIANGLE PARK, N.C., March 15, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced [...]
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
15/03/2024
36,000 people across 17 markets responded to the company’s fourth annual survey. 40% of respondents get no more than three nights of good sleep per week. More than one-third of respondents are now actively tracking [...]
Mendus’ major shareholders and members of the Board of Directors and Management declare their intention to exercise warrants of series TO3
15/03/2024
Press Release Stockholm, Sweden, March 15, 2024 Mendus AB (“Mendus” or the “Company”) has received written declarations of intent whereby the Company’s major shareholders, holding approximately 65.8 percent of shares in [...]
The exercise period for warrants of series TO3 commences today
15/03/2024
Press Release Stockholm, Sweden, March 15, 2024 On June 8, 2023, Mendus AB (publ) (“Mendus” or the “Company”), (NASDAQ Stockholm: IMMU), announced that the Board of Directors had resolved on a capital raise of [...]
ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial Highlights
15/03/2024
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Company expects to commercialize its ARC-EX ® System and commence the Empower BP [...]
ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing
15/03/2024
Erika Ross rejoint la société en tant que VP Global Clinical & Regulatory, et Sarah Moore au poste de VP Global Marketing EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 15 mars 2024 (GLOBE [...]
Vivoryon Therapeutics N.V. Announces Changes to Board Composition
15/03/2024
Vivoryon Therapeutics N.V. Announces Changes to Board Composition Halle (Saale) / Munich, Germany, March 15, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage [...]
Ibogaine By David Dardashti Explores Chemistry of Treatment for Long Term Opiate Abuse
15/03/2024
David Dardashti's Studies Reveal Powerful Effects of Pure Ibogaine Hydrochloride PLAYA DEL CARMEN, Mexico, March 14, 2024 (GLOBE NEWSWIRE) -- David Dardashti describes his discovery of ibogaine treatment for long term [...]
Common Skin Cancer, Like Christie Brinkley’s, Can Often Be Cured Without Surgery
14/03/2024
BURR RIDGE, Ill., March 14, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology , the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT) for the [...]
Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting
14/03/2024
Anaphylm meets all predefined primary and secondary pharmacokinetic endpoints Anaphylm time to maximum concentration (Tmax) is consistently faster than autoinjectors Anaphylm exposure levels (AUC) are comparable to [...]
Digicann Ventures Announces Granting of Forbearance for Convertible Debenture Maturity Date
14/03/2024
VANCOUVER, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAF), a company focused on opportunities within and outside of the cannabis [...]
TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024
14/03/2024
FORT WORTH, Texas, March 14, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its [...]
BrightSpring Health Services’ Specialty Pharmacy Onco360® Celebrates Excellent Patient Care and Preferred Pharmacy Status
14/03/2024
LOUISVILLE, Ky., March 14, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) announced today that its company, Onco360 ® , one of the nation’s [...]
Onco360® Celebrates Excellent Patient Care, Reflected by Impressive Net Promoter Score
14/03/2024
LOUISVILLE, Ky., March 14, 2024 (GLOBE NEWSWIRE) -- This year, Onco360 ® , the nation’s leading independent specialty oncology pharmacy, celebrates excellent service and care that resulted in unmatched patient [...]
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
14/03/2024
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused building innovative microbial protein [...]
Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5
14/03/2024
Da Vinci 5 builds on decades of Intuitive technology and millions of robotic procedures SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive [...]
IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Follow
14/03/2024
SAINT LAURENT, Quebec, March 14, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its fourth quarter and [...]

Pages